GINO SANTINI Insider Trading
Get free email notifications about insider trading for GINO SANTINI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GINO SANTINI. GINO SANTINI is a Director in AMAG PHARMACEUTICALS INC. ($AVM) and a President, US Operations in LILLY ELI & CO ($LLY) and a Sr.VP, Corp. Strategy & BD in LILLY ELI & CO ($LLY) and a Sr.VP, Corp. Strategy & Policy in LILLY ELI & CO ($LLY) and a Director in Vitae Pharmaceuticals, Inc ($VTAE) and a Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and a Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a Director in Horizon Pharma plc ($HZNP) and a Director in Allena Pharmaceuticals, Inc. ($ALNA).
Over the past year GINO SANTINI has been an insider in 5 companies. The total value of shares held by GINO SANTINI in these companies amounts to $1,721,889.
GINO SANTINI ranks 12,924 out of 350,000 insiders. Go to Insider Ranking to see more.
Address: LILLY CORPORATE CENTER INDIANAPOLIS 46285 IN
Companies in which GINO SANTINI is an Insider
Allena Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GINO SANTINI: Director
Holdings: 0 shares
Latest Transaction: Jun 07 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AMAG PHARMACEUTICALS INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 31,204 shares
Latest Transaction: May 20 2019
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions
Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 21,007
Shares Sold: 0
Share Difference: +21,007
Value Difference: $0
COLLEGIUM PHARMACEUTICAL, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 30,148 shares
Current Value: $463,073
Latest Transaction: Apr 29 2019
$COLL Market Capitalization: $351.67M
$COLL Previous Close: $15.36
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions
Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 6,960
Shares Sold: 0
Share Difference: +6,960
Value Difference: $0
Horizon Therapeutics Public Ltd Co
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 36,173 shares
Current Value: $609,877
Latest Transaction: May 06 2019
$HZNP Market Capitalization: $2.68B
$HZNP Previous Close: $16.86
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions
Last 3 Months Overview:
Buy: 4x
Sell: 4x
Shares Bought: 48,585
Shares Sold: 18,426
Share Difference: +30,159
Value Difference: +$337,960
INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 5,714 shares
Current Value: $648,939
Latest Transaction: Jun 22 2018
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions
Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 4,414
Shares Sold: 0
Share Difference: +4,414
Value Difference: $0
LILLY ELI & CO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Sr.VP, Corp. Strategy & BD, Sr.VP, Corp. Strategy & Policy, President, US Operations
Holdings: 102,174 shares
Current Value: $7,938,920
Latest Transaction: Feb 03 2009
$LLY Market Capitalization: $83.74B
$LLY Previous Close: $77.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vitae Pharmaceuticals, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GINO SANTINI: Director
Holdings: 0 shares
Latest Transaction: Oct 25 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GINO SANTINI
Sentiment: All, ALNA, AVM, COLL, HZNP, ICPT, LLY, VTAE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 07 2019 | ALNA | Allena Pharmaceuti ... | SANTINI GINO | Director | Option Exercise | A | 5.59 | 14,000 | 78,260 | 14,000 | |
| May 20 2019 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | A | 10.78 | 17,326 | 186,774 | 17,326 | |
| May 20 2019 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Grant | A | 0.00 | 8,116 | 0 | 31,204 | 23.1 K to 31.2 K (+35.15 %) |
| May 06 2019 | HZNP | Horizon Therapeuti ... | SANTINI GINO | Director | Option Exercise | M | 0.00 | 15,320 | 0 | 0 | |
| May 06 2019 | HZNP | Horizon Therapeuti ... | SANTINI GINO | Director | Option Exercise | A | 0.00 | 15,390 | 0 | 15,390 | |
| May 06 2019 | HZNP | Horizon Therapeuti ... | SANTINI GINO | Director | Payment of Exercise | F | 26.54 | 6,014 | 159,612 | 30,159 | 36.2 K to 30.2 K (-16.63 %) |
| May 06 2019 | HZNP | Horizon Therapeuti ... | SANTINI GINO | Director | Buy | M | 0.00 | 15,320 | 0 | 36,173 | 20.9 K to 36.2 K (+73.47 %) |